These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 12901246)

  • 1. Radiofrequency ablation for the management of liver tumors.
    Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
    Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
    Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
    Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiofrequency ablation in primary and secondary liver tumors].
    Carditello A; Scisca C; David A; Stilo F; Basile M
    Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis].
    Bonny C; Abergel A; Gayard P; Chouzet S; Ughetto S; Slim K; Rosenfeld L; Guillon R; Poincloux L; Bommelaer G
    Gastroenterol Clin Biol; 2002; 26(8-9):735-41. PubMed ID: 12434078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
    Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
    J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
    Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
    J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients.
    Gunabushanam G; Sharma S; Thulkar S; Srivastava DN; Rath GK; Julka PK; Bhatnagar S
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):67-72. PubMed ID: 17296706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results.
    Poggi G; Montagna B; DI Cesare P; Riva G; Bernardo G; Mazzucco M; Riccardi A
    Anticancer Res; 2013 Mar; 33(3):1221-7. PubMed ID: 23482806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.